Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.54 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | NPC1 | O15118 | 7/20 | 0.54 |
| ▸ | RAB9A | P51151 | 7/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.54 |
| ▸ | LMNA | P02545 | 4/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.54 |
| ▸ | POLB | P06746 | 3/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | GLA | P06280 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19474912 | 0.89 | KMT2A (0.53) | KMT2AMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL19469424 | 0.89 | KMT2A (0.53) | KMT2AMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL19474911 | 0.89 | KMT2A (0.53) | KMT2AMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL19506136 | 0.77 | KMT2A (0.53) | KMT2AMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1889486 | 0.77 | NPC1 (0.59) | KMT2AMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL15105974 | 0.77 | DPP4 (0.54) | KMT2AMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL24922336 | 0.76 | MAPT (0.51) | KMT2AMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL11153838 | 0.76 | KMT2A (0.72) | KMT2AMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4909719 | 0.76 | KMT2A (0.63) | KMT2AMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL9360486 | 0.76 | KMT2A (0.72) | KMT2AMAPTNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119277948-A | Perovskite passivation material, passivation unit and perovskite battery | 天合光能股份有限公司 | 2025-01-07 | — | — | CN | claimed |
| US-20200388881-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL THIOPHENE COMPOUNDS OR DERIVATIVES OF THIOPHENE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | claimed |
| CN-119277948-A | Perovskite passivation material, passivation unit and perovskite battery | 天合光能股份有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-118287150-A | Method for efficiently catalyzing Knoevenagel condensation reaction by porphyrin and quaternary ammonium salt synergistic catalytic system | 沈阳药科大学 | 2024-07-05 | — | — | CN | disclosed |
| CN-117919443-A | Covalent organic framework combining diagnosis of hypoxia-activated therapy and self-accelerating drug release to coordinate cancer immunotherapy | 长春工业大学 | 2024-04-26 | — | — | CN | disclosed |
| CN-117623983-A | Method for constructing cyclopentene skeleton by directly cyclizing allyl alcohol | 南京工业大学 | 2024-03-01 | — | — | CN | disclosed |
| US-11569530-B2 | Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives | ENEVATE CORPORATION (US) | 2023-01-31 | — | — | US | disclosed |
| US-11352500-B2 | Squaraine-based molecules as material for organic photoelectric conversion layers in organic photodiodes | SONY CORPORATION (JP) | 2022-06-07 | — | — | US | disclosed |
| US-20200388881-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL THIOPHENE COMPOUNDS OR DERIVATIVES OF THIOPHENE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | disclosed |
| US-20200388881-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL THIOPHENE COMPOUNDS OR DERIVATIVES OF THIOPHENE CONTAINING ELECTROLYTE ADDITIVES | ENEVATE CORPORATION | 2020-12-10 | — | — | US | disclosed |
| EP-3172272-B1 | MODIFIED HETEROPHASIC POLYOLEFIN COMPOSITION | MILLIKEN & CO (US) | 2020-11-25 | — | — | EP | disclosed |
| US-20120289506-A1 | 5-MEMBERED NITROGEN CONTAINING HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2012-11-15 | — | — | US | disclosed |
| US-8227500-B2 | 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2012-07-24 | — | — | US | disclosed |
| US-20110028656-A1 | Band gap control in conjugated oligomers and polymers via Lewis acids | NAVY, SECRETARY OF THE UNITED STATES OF AMERICA | 2011-02-03 | — | — | US | disclosed |
| US-20100227864-A1 | 5-MEMBERED HETEROCYCLIC DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES | KISSEI PHARMACEUTICAL CO., LTD. (JP) | 2010-09-09 | — | — | US | disclosed |
| EP-2133331-A1 | 5-MEMBERED HETEROCYCLIC DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES | Kissei Pharmaceutical Co., Ltd. (JP) | 2009-12-16 | — | — | EP | disclosed |
| EP-1305026-B1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | NOVUSPHARMA SPA (IT) | 2009-05-13 | — | — | EP | disclosed |
| US-20080113993-A1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | VIA ARIOSTO, 23 (IT) | 2008-05-15 | — | — | US | disclosed |
| US-20080113993-A1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | VIA ARIOSTO, 23 (IT) | 2008-05-15 | — | — | US | disclosed |
| US-4184871-A | A,B-UNSATURATED NITRILE SENSITIZER | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JP) | 1980-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100227864-A1 | 5-MEMBERED HETEROCYCLIC DERIVATIVE AND USE THEREOF FOR MEDICAL PURPOSES | XDH, DAO, CBR1 | KMT2A 1484/4885MAPT 4761/4885NPC1 1996/4885 |
| US-11569530-B2 | Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives | TST, SELENOI, SELE | KMT2A 1639/4885MAPT 2243/4885NPC1 3178/4885 |
| US-20120289506-A1 | 5-MEMBERED NITROGEN CONTAINING HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | XDH, DAO, DDO | KMT2A 1715/4885MAPT 4363/4885NPC1 1790/4885 |
| US-20080113993-A1 | BARBITURIC ACID ANALOGS AS THERAPEUTIC AGENTS | HIF1A, HIF1AN, PDGFA | KMT2A 418/4885MAPT 3423/4885NPC1 2098/4885 |
| US-20200388881-A1 | SILICON-BASED ENERGY STORAGE DEVICES WITH FUNCTIONAL THIOPHENE COMPOUNDS OR DERIVATIVES OF THIOPHENE CONTAINING ELECTROLYTE ADDITIVES | TST, SELENOI, SELE | KMT2A 1639/4885MAPT 2243/4885NPC1 3178/4885 |
| US-20110028656-A1 | Band gap control in conjugated oligomers and polymers via Lewis acids | PCNA, CLTB, GJB2 | KMT2A 2226/4885MAPT 2207/4885NPC1 4502/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.